EFFICACY AND SAFETY EVALUATION OF ALIROCUMAB IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA OR HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA ON LIPID MODIFYING THERAPY (ODYSSEY JAPAN):